Financials
Financial year 2025
FOMIVAMED from Braine-l'Alleud, company number BE0887305619, closed financial year 2025 with a result of € 64,501 after tax. For that financial year FOMIVAMED recorded a gross margin of € 115,245 and equity of € 267,306. Compared with financial year 2024, the result moved from € 31,357 to € 64,501. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 18, 2026.
€ 267,306
▲ 32% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 64,501
▲ 106% vs 2024
Profit after tax over the fiscal year.
€ 5,770
▼ 86% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 254,906.
People and assets in 2025
€ 683
▼ 71% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 320,746
▼ 6% vs 2024
€ 22,542 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.
€ 9,215
▼ 37% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 141,588 | € 162,969 | € 104,029 | € 115,245 | ▲ 11% |
| Profit after taxes | € 100,416 | € 129,204 | € 31,357 | € 64,501 | ▲ 106% |
| Equity | € 131,644 | € 185,848 | € 202,805 | € 267,306 | ▲ 32% |
| Total debts | € 103,769 | € 111,470 | € 388,885 | € 335,600 | ▼ 14% |
| Cash | € 33,205 | € 37,991 | € 41,033 | € 5,770 | ▼ 86% |
| Land & buildings | - | - | € 367,489 | € 393,983 | ▲ 7% |
| Retained profit | € 119,244 | € 173,448 | € 190,405 | € 254,906 | ▲ 34% |
| Dividend | € 75,000 | € 75,000 | € 14,400 | € 0 | ▼ 100% |
| Bank debt | € 0 | € 87 | € 342,113 | € 320,746 | ▼ 6% |
| Balance sheet total | € 235,412 | € 297,318 | € 591,689 | € 602,905 | ▲ 2% |
Key figures of FOMIVAMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 1 February 2027.
What happened to FOMIVAMED?
What happened at FOMIVAMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 64,501 (▲ 106% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Boussu. KBO
- Guy FOMEGNE NGASSA became a director. NBB
In short
From € 100,416 profit in 2022 to € 64,501 profit in 2025.
Paid € 73,765 in corporate taxes since 2022.
Best year ever: 2023, with € 129,204 profit.
Paid out € 164,400 in dividends to the owners in total.
Management
Behind FOMIVAMED is Guy FOMEGNE NGASSA.
Directors
According to the 2025 annual accounts
Guy FOMEGNE NGASSA
Managing director
since 2007
Establishments
Establishment units
Physical locations of this company
Rue du Château d'Eau 3
1420 Braine-l'Alleud
Rue de Mons(H) 63
7301 Boussu
Active since 12 February 2007
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- FOMEGNE Guy Léopold(oprichter) 100%
Details
- Company number
- 0887.305.619
- VAT number
- BE 0887.305.619
- Registered office
- Rue du Château d'Eau 3, 1420 Braine-l'Alleud
- Names & denominations
- FOMIVAMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 February 2007
- Peppol
- Active · Active since 5 Jan 2026